small molecule

NEREUS

TRADIPITANT

Loss of exclusivityAugust 2036latest FDA-listed patent expiry

CompanyVanda Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand name	NEREUS
Active ingredient	TRADIPITANT
Strength	85MG
Dosage form	CAPSULE
Route	ORAL
Modality	Small molecule
FDA approval	December 2025
Marketing status	RX

Listed patents

Patent	Expires	Type
12318375	August 2036	use U-4396
11324735	March 2036	use U-4396
10821099	March 2036	use U-4396
10772880	March 2036	use U-4396

Regulatory exclusivity

Code	Expires
NCE	December 2030

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from Vanda Pharmaceuticals